Plain-English translation of NCT07605416 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
The QUANTUM trial is testing a new treatment plan for people with plasma cell leukemia, a rare blood cancer. The study compares two approaches: one using standard chemotherapy drugs after a stem cell transplant, and another using an experimental medication called after the transplant. is a specially designed antibody that targets cancer cells and recruits the body's immune cells to fight them.
Plasma cell leukemia is an aggressive cancer that doesn't respond well to existing treatments, and people with it need better options. Researchers believe that this medication might help patients achieve longer survival and better cancer control when combined with stem cell transplantation and other treatments.
You likely qualify if…
You likely don't qualify if…
You would receive four months of chemotherapy treatment with multiple drugs given by IV or by mouth to shrink the cancer. Then you would undergo a stem cell transplant (your own cells are collected, stored, and returned to you after high-dose treatment). After recovery, you would receive additional treatment with either standard chemotherapy drugs or the experimental medication , followed by maintenance therapy for up to 2 years. You would have regular clinic visits, blood tests, and scans to monitor how well the treatment is working and watch for any side effects.
AI-generated summary from trial data · Oct 7, 2026 · Not medical advice
United States